补充维生素A、B、C、D、E对COVID-19患者疾病严重程度和炎症反应的影响:一项随机临床试验
在ICU收治的COVID-19患者中开展随机单盲临床试验,60例随机分为干预组(n=30)和对照组(n=30)。干预组接受维生素A、B、C、D、E补充7天,对照组不给予任何维生素或安慰剂。结果显示干预组维生素水平、炎症标志物及SOFA评分较对照组有显著变化,死亡率无统计学差异,住院超过7天的比例显著降低,但校正混杂因素后该关联不显著。
要点
- 干预组维生素A、B、C、D、E补充7天后,所有维生素血清水平较对照组有显著变化(p < 0.001)。
- 干预组ESR、CRP、IL6、TNF-a及SOFA评分较对照组有显著改善。
- 死亡率在两组间无统计学差异(p=0.112)。
核心结论
- 补充维生素A、B、C、D、E可改善ICU收治的COVID-19患者的炎症反应并降低疾病严重程度。
研究设计与样本
- 随机单盲临床试验,共纳入60例ICU收治的COVID-19患者,随机分为干预组(n=30)和对照组(n=30)。
- 干预组接受维生素A、B、C、D、E补充7天,对照组不给予任何维生素或安慰剂。
- 干预方案为:维生素A每日25,000 IU;维生素D在研究期间一次性给予600,000 IU;维生素E每日两次每次300 IU;维生素C每日四次每次500 mg;复合维生素B每日一支,持续7天。
- 在基线和7天干预后评估炎症标志物、维生素血清水平及SOFA评分,干预后评估死亡率和住院时长。
主要发现
- 与对照组相比,干预后所有维生素血清水平均有显著变化(p < 0.001)。
- 与对照组相比,干预后ESR(p < 0.001)、CRP(p = 0.001)、IL6(p = 0.003)、TNF-a(p = 0.001)及SOFA评分(p < 0.001)均有显著变化。
- 维生素对死亡率的影响无统计学意义(p=0.112)。
- 干预组住院超过7天的比例显著低于对照组(p=0.001)。
- 未校正时,接受干预与住院超过7天存在显著负相关(OR = 0.135,95% CI 0.038-0.481;p=0.002);校正混杂因素后不显著(OR=0.402,95% CI 0.086-1.883;p=0.247)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Because of the effect of vitamins on modulating the immune system function, we have evaluated the effect of supplementation with vitamins A, B, C, D, and E in ICU-admitted patients with COVID-19. METHODS: This study was a randomized and single-blinded clinical trial in which 60 subjects were randomly assigned to two groups. The intervention group (n=30) received vitamins, and the control group did not receive any vitamin or placebo. The intervention was included 25,000 IU daily of vitamins A, 600,000 IU once during the study of D, 300 IU twice daily of E, 500 mg four times daily of C, and one amp daily of B complex for 7 days. At baseline and after the 7-day intervention, the serum levels of inflammatory markers, vitamins, and the SOFA score were assessed. In addition, the mortality rate and duration of hospitalization were evaluated after the intervention (IRCT registration number: IRCT20200319046819N1/registration date: 2020-04-04, https://www.irct.ir/trial/46838 ). RESULTS: Significant changes were detected in serum levels of vitamins (p < 0.001 for all vitamins), ESR (p < 0.001), CRP (p = 0.001), IL6 (p = 0.003), TNF-a (p = 0.001), and SOFA score (p < 0.001) after intervention compared with the control group. The effect of vitamins on the mortality rate was not statistically significant (p=0.112). The prolonged hospitalization rate to more than 7 days was significantly lower in the intervention group than the control group (p=0.001). Regarding the effect size, there was a significant and inverse association between receiving the intervention and prolonged hospitalization (OR = 0.135, 95% CI 0.038-0.481; p=0.002); however, after adjusting for confounders, it was not significant (OR=0.402, 95% CI 0.086-1.883; p=0.247). CONCLUSION: Supplementation with vitamins A, B, C, D, and E could improve the inflammatory response and decrease the severity of disease in ICU-admitted patients with COVID-19.
引用
- Beigmohammadi MT, Bitarafan S, Hoseindokht A, et al. The effect of supplementation with vitamins A, B, C, D, and E on disease severity and inflammatory responses in patients with COVID-19: a randomized clinical trial. Trials. 2021. PMID: 34776002. doi:10.1186/s13063-021-05795-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。